Floatz logo

2-Bromo-?-ergocryptine

Traumatic Brain Injury

University of California, San FranciscoSmall moleculePhase 1/2Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
73/ 100

Competitive context

93 Active assets in the Traumatic Brain Injury cohort.

Asset / SponsorPhaseRating
MELATONIN
Children's National Research Institute
Phase 4BBB
Valproic Acid
Northwestern University
Phase 4BBB
PROPRANOLOL
Tanta University
Phase 4BBB
NEPENTHE
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB
N-Acetyl-L-Cysteine
HonorHealth Research Institute
Phase 2BB

View all 50 →

Same molecule, other indications

2-Bromo-?-ergocryptine is also rated in:

Parkinson diseaseDormant
BB
Indicative ·
69 / 100
View asset →
prediabetes syndromeDormant
BB
Indicative ·
65 / 100
View asset →
eating disorderDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →